{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T18:08:30Z","timestamp":1783966110635,"version":"3.55.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>\n                      Microvascular inflammation (MVI) has long been considered a hallmark of antibody-mediated rejection (AMR). However, the 2022 Banff classification introduced isolated MVI (iMVI; MVI\n                      <jats:sup>+<\/jats:sup>\n                      \/donor-specific antibody [DSA]\n                      <jats:sup>\u2212<\/jats:sup>\n                      \/C4d\n                      <jats:sup>\u2212<\/jats:sup>\n                      ) as a distinct phenotype. The biological characteristics and clinical significance of iMVI remain incompletely understood.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>\n                      Kidney transplant recipients who underwent allograft biopsy between 2013 and 2024 were classified into iMVI, AMR (MVI\n                      <jats:sup>+<\/jats:sup>\n                      \/DSA\n                      <jats:sup>+<\/jats:sup>\n                      \/C4d\n                      <jats:sup>+<\/jats:sup>\n                      ), and acute tubular injury (ATI; MVI\n                      <jats:sup>\u2212<\/jats:sup>\n                      \/DSA\n                      <jats:sup>\u2212<\/jats:sup>\n                      \/C4d\n                      <jats:sup>\u2212<\/jats:sup>\n                      ). After propensity score matching, 80 patients (30 iMVI, 30 AMR, and 20 ATI) compromised the main cohort. An independent validation cohort (n\u2005=\u200588; 26 iMVI, 26 AMR, 26 T-cell\u2013mediated rejection, 10 ATI) was additionally assembled. Serum proteomic profiling was performed using a proximity extension assay.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>iMVI exhibited a distinct proteomic profile enriched for innate and cytotoxic immune activation proteins, including tumor necrosis factor receptor superfamily member 9, programmed death-ligand 1, interleukin-15 receptor subunit alpha, fibroblast growth factor 19, C-X3-C motif chemokine ligand 1, C-C motif chemokine ligand 23, signaling lymphocytic activation molecule family member 1, and interleukin-10 receptor subunit beta with enrichment of natural killer cell differentiation and leukocyte migration pathway. In contrast, AMR showed higher expression of adaptive and humoral immune mediators, including interleukin-33, interleukin-2, TNF-related apoptosis-inducing ligand, and interleukin-2 receptor subunit beta with enrichment of immunoglobulin production and interferon-\u03b3\u2013related adaptive immune pathways. Protein risk scores showed strong discriminative performance in the main cohort (area under the curve, 0.856 for iMVI; 0.879 for AMR) and retained significant ability in the validation cohort (area under the curve, 0.708 and 0.689, respectively). Several iMVI-enriched proteins were significantly associated with increased risk of death-censored graft loss.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>iMVI is characterized by dominant innate and cytotoxic immune activation distinct from AMR and is associated with adverse graft outcomes, supporting its recognition as a clinically meaningful phenotype beyond conventional AMR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005839","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T18:03:44Z","timestamp":1783965824000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Serum Proteomic Profiles of Microvascular Inflammation in Donor-specific Antibody-negative and C4d-negative in Kidney Transplantation"],"prefix":"10.1097","author":[{"given":"Hee Byung","family":"Koh","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jeong","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Woo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byounghwi","family":"Ko","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyu","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jeong","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhan","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Seok","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Ha","family":"Huh","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeseok","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"R1-20260713","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajt.2023.10.016","article-title":"The Banff 2022 kidney meeting report: reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics.","volume":"24","author":"Naesens","year":"2024","journal-title":"Am J Transplant"},{"key":"R2-20260713","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJMoa2408835","article-title":"Microvascular inflammation of kidney allografts and clinical outcomes.","volume":"392","author":"Sablik","year":"2025","journal-title":"N Engl J Med"},{"key":"R3-20260713","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrneph.2014.247","article-title":"Proteomic biomarkers in kidney disease: issues in development and implementation.","volume":"11","author":"Mischak","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"R4-20260713","doi-asserted-by":"crossref","first-page":"e15410","DOI":"10.1111\/ctr.15410","article-title":"T-cell mediated rejection associated microvascular inflammation in the allograft kidney: RNAseq analysis using the Banff human organ transplant gene panel.","volume":"38","author":"Barwad","year":"2024","journal-title":"Clin Transplant"},{"key":"R5-20260713","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.immuni.2016.04.019","article-title":"The TNF receptor superfamily in co-stimulating and co-inhibitory responses.","volume":"44","author":"Ward-Kavanagh","year":"2016","journal-title":"Immunity"},{"key":"R6-20260713","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41581-025-01029-x","article-title":"Natural killer cells in kidney immune surveillance, injury and fibrosis.","volume":"22","author":"Horowitz","year":"2026","journal-title":"Nat Rev Nephrol"},{"key":"R7-20260713","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.4049\/jimmunol.164.8.4055","article-title":"Fractalkine-mediated endothelial cell injury by NK cells.","volume":"164","author":"Yoneda","year":"2000","journal-title":"J Immunol"},{"key":"R8-20260713","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clim.2018.10.011","article-title":"SLAM family receptors in natural killer cells\u2014mediators of adhesion, activation and inhibition via cis and trans interactions.","volume":"204","author":"Claus","year":"2019","journal-title":"Clin Immunol"},{"key":"R9-20260713","doi-asserted-by":"crossref","first-page":"584626","DOI":"10.3389\/fimmu.2020.584626","article-title":"Regulation of PD-L1 expression by NF-\u03baB in cancer.","volume":"11","author":"Antonangeli","year":"2020","journal-title":"Front Immunol"},{"key":"R10-20260713","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ajt.2022.12.018","article-title":"Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d: an orphan category in Banff classification with cytotoxic T and natural killer cell infiltration.","volume":"23","author":"Buxeda","year":"2023","journal-title":"Am J Transplant"},{"key":"R11-20260713","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1038\/s41467-023-39859-7","article-title":"Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection.","volume":"14","author":"Lamarth\u00e9e","year":"2023","journal-title":"Nat Commun"},{"key":"R12-20260713","first-page":"844","article-title":"Serum interleukin-2 and soluble interleukin-2 receptor in renal transplant recipients.","volume":"91","author":"Lee","year":"1992","journal-title":"J Formos Med Assoc"},{"key":"R13-20260713","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.immuni.2015.06.006","article-title":"Interleukin-33 in tissue homeostasis, injury, and inflammation.","volume":"42","author":"Molofsky","year":"2015","journal-title":"Immunity"},{"key":"R14-20260713","doi-asserted-by":"crossref","first-page":"112705","DOI":"10.1016\/j.yexcr.2021.112705","article-title":"Role of the IL-33\/ST2 pathway in renal allograft rejection.","volume":"405","author":"Yu","year":"2021","journal-title":"Exp Cell Res"},{"key":"R15-20260713","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3390\/diagnostics11091574","article-title":"CD5-positive B lymphocytes after kidney transplantation.","volume":"11","author":"Zieli\u0144ski","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"R16-20260713","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ki.2010.162","article-title":"Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype.","volume":"78","author":"Pallier","year":"2010","journal-title":"Kidney Int"},{"key":"R17-20260713","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1111\/ajt.17092","article-title":"Molecular diagnosis of ABMR with or without donor-specific antibody in kidney transplant biopsies: differences in timing and intensity but similar mechanisms and outcomes.","volume":"22","author":"Halloran","year":"2022","journal-title":"Am J Transplant"},{"key":"R18-20260713","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1681\/ASN.2020030306","article-title":"Transcriptional changes in kidney allografts with histology of antibody-mediated rejection without anti-HLA donor-specific antibodies.","volume":"31","author":"Callemeyn","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"R19-20260713","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/ajt.14645","article-title":"Neutrophil derived CSF1 induces macrophage polarization and promotes transplantation tolerance.","volume":"18","author":"Braza","year":"2018","journal-title":"Am J Transplant"},{"key":"R20-20260713","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.4049\/jimmunol.167.11.6210","article-title":"2B4 (CD244)-mediated activation of cytotoxicity and IFN-gamma release in human NK cells involves distinct pathways.","volume":"167","author":"Chuang","year":"2001","journal-title":"J Immunol"},{"key":"R21-20260713","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/ATVBAHA.112.248773","article-title":"Synergistic effect of thrombin and CD40 ligand on endothelial matrix metalloproteinase-10 expression and microparticle generation in vitro and in vivo.","volume":"32","author":"Mart\u00ednez de Lizarrondo","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R22-20260713","doi-asserted-by":"crossref","first-page":"e63555","DOI":"10.1371\/journal.pone.0063555","article-title":"Macrophage migration and invasion is regulated by MMP10 expression.","volume":"8","author":"Murray","year":"2013","journal-title":"PLoS One"},{"key":"R23-20260713","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1161\/CIRCULATIONAHA.110.017012","article-title":"Urokinase-type plasminogen activator promotes paracellular transmigration of neutrophils via Mac-1, but independently of urokinase-type plasminogen activator receptor.","volume":"124","author":"Reichel","year":"2011","journal-title":"Circulation"},{"key":"R24-20260713","doi-asserted-by":"crossref","first-page":"e56830","DOI":"10.1371\/journal.pone.0056830","article-title":"TWEAK enhances E-selectin and ICAM-1 expression, and may contribute to the development of cutaneous vasculitis.","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"R25-20260713","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.clim.2012.08.008","article-title":"Inhibition of the TWEAK\/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis.","volume":"145","author":"Xia","year":"2012","journal-title":"Clin Immunol"},{"key":"R26-20260713","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2024.02.001","article-title":"Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer.","volume":"57","author":"Shouse","year":"2024","journal-title":"Immunity"},{"key":"R27-20260713","doi-asserted-by":"crossref","first-page":"610789","DOI":"10.3389\/fimmu.2021.610789","article-title":"Transcription factors associated with IL-15 cytokine signaling during NK cell development.","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"R28-20260713","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/physrev.00045.2017","article-title":"The TNF family of ligands and receptors: communication modules in the immune system and beyond.","volume":"99","author":"Dostert","year":"2019","journal-title":"Physiol Rev"},{"key":"R29-20260713","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00011-011-0350-5","article-title":"Potential involvement of CCL23 in atherosclerotic lesion formation\/progression by the enhancement of chemotaxis, adhesion molecule expression, and MMP-2 release from monocytes.","volume":"60","author":"Kim","year":"2011","journal-title":"Inflamm Res"},{"key":"R30-20260713","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.cyto.2005.01.018","article-title":"Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis.","volume":"30","author":"Hwang","year":"2005","journal-title":"Cytokine"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005839","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T18:03:48Z","timestamp":1783965828000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":30,"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005839","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]}}}